Iovance Surged 44% This Week and Its Philadelphia Factory Explains Why
Iovance Biotherapeutics transformed from a pipeline company to a profitable commercial entity with proprietary manufacturing capabilities, driving a 43% stock surge after Q4 2025 earnings.
Netflix's 'throne is secured,' BofA said just before Paramount mounted one last streaming war, hoping to keep Superman off the super app | Fortune
Netflix's acquisition of Warner Bros. Discovery studios and streaming assets secures its streaming dominance and materially widens competitors' strategic disadvantage.
Early investment in manufacturing and operations created a durable competitive moat that now enables Framebridge to scale rapidly and expand physical retail presence.